Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.45 -0.02 (-4.66%)
As of: Nov 16, 2026 · 3:48 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Preferred Stock Liabilities (2015)

Updated

Protagenic Therapeutics, Inc.new (PTIX) recorded Preferred Stock Liabilities of $1,569 in fiscal Q4 2015 (quarter ended Dec 31, 2015).

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Preferred Stock Liabilities (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Protagenic Therapeutics, Inc.new 850,797.76 -4.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 1,569.00
API Access

Protagenic Therapeutics, Inc.new Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PTIX&period=max&api_key=YOUR_API_KEY